Measuring the return from pharmaceutical innovation 2016

Balancing the R&D equation

The seventh annual pharmaceutical innovation study, co-produced by the Deloitte Center for Health Solutions in the US and the UK, looks at the challenges the industry faces in generating returns from its R&D investments. The report also highlights key strategies to help increase pipeline value while reducing R&D costs to generate sustainable returns.

Did you find this useful?